- Forums
- ASX - By Stock
- MSB
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-283
-
- There are more pages in this discussion • 725 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
0.058(5.99%) |
Mkt cap ! $1.147B |
Open | High | Low | Value | Volume |
96.5¢ | $1.03 | 96.5¢ | $2.812M | 2.820M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1406 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 59397 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1406 | 1.015 |
14 | 163743 | 1.010 |
8 | 97423 | 1.005 |
17 | 215990 | 1.000 |
6 | 549049 | 0.995 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 48905 | 6 |
1.025 | 264660 | 5 |
1.030 | 16842 | 9 |
1.035 | 26569 | 9 |
1.040 | 40195 | 3 |
Last trade - 11.59am 14/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online